Rna formulation for immunotherapy

作者: Sebastian Kreiter , Martin Meng , Ugur Sahin , Daniel Fritz , Heinrich Haas

DOI:

关键词:

摘要: The present invention is in the field of immunotherapy, particular tumor immunotherapy. provides pharmaceutical formulations for delivering RNA to antigen presenting cells such as dendrite (DCs) spleen after systemic administration. In particular, described herein enable induce an immune response administration antigen-coding RNA.

参考文章(171)
Akira Yamada, [Peptide-based cancer vaccine therapy for prostate cancer, bladder cancer, and malignant glioma]. Nihon rinsho. Japanese journal of clinical medicine. ,vol. 69, pp. 1657- ,(2011)
Özlem Türeci, Sebastian Kreiter, Ugur Sahin, Abderraouf Selmi, Use of flt3 ligand for strengthening immune responses in rna immunization ,(2009)
Sander Dollner, Torsten Bönsch, Johannes Bais, Marcus Ludwig, Device for foaming milk, beverage maker comprising said device, and method for foaming milk ,(2012)
Heinz Kölbl, Hans Georg W. Leuenberger, Bertrand Nagel, A multilingual glossary of biotechnological terms : IUPAC recommendations Verlag Helvetica Chimica Acta , VCH [distributor]. ,(1995)
Arnaud Vonarbourg, Catherine Passirani, Patrick Saulnier, Bruno Pitard, Jean-Pierre Benoit, Olivier Lambert, Nanocapsules of lipophilic complexes of nucleic acids ,(2008)
Nir Hacohen, Catherine Ju-Ying Wu, Edward F. Fritsch, Compositions and methods for personalized neoplasia vaccines ,(2014)
Christopher R. Conlee, Andrew W. Fraley, Atanu Roy, Antonin De Fougerolles, Alternative nucleic acid molecules and uses thereof ,(2015)